Study: Blood Test for Prostate Cancer Can Guide Therapy, Extend Lives
Xconomy
JULY 2, 2018
A paper published last week in the journal JAMA Oncology makes the case that one such test, Oncotype DX AR-V7 Nucleus Detect, might be worth its $3,980 price tag. Earlier this year, the federal insurance program Medicare sent positive signals about coverage but hasn’t made a final decision.)
Let's personalize your content